Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-03 | Vera Therapeutics, Inc. | Grant Sean
(CHIEF FINANCIAL OFFICER) |
S | Class A Common Stock | D | 118477 | $38.12 - $40.06 | $4,689,713 |
2024-04-03 | Vera Therapeutics, Inc. | Grant Sean
(CHIEF FINANCIAL OFFICER) |
M | Class A Common Stock | A | 99828 | $14.87 - $14.87 | $1,484,442 |
2023-03-14 | Vera Therapeutics, Inc. | Grant Sean
(CHIEF FINANCIAL OFFICER) |
G | Class A Common Stock | D | 32446 | $0.00 - $0.00 | $0 |
2024-03-21 | Vera Therapeutics, Inc. | Katabi Maha
(Director) |
S | Class A Common Stock | D | 834459 | $40.50 - $46.18 | $34,099,581 |
2024-01-30 | Vera Therapeutics, Inc. | Katabi Maha
(Director) |
P | Class A Common Stock | A | 161290 | $31.00 - $31.00 | $4,999,990 |
2024-01-16 | Vera Therapeutics, Inc. | Fordyce Marshall
(PRESIDENT AND CEO) |
A | Class A Common Stock | A | 78750 | $0.00 - $0.00 | $0 |
2024-01-16 | Vera Therapeutics, Inc. | Young Joseph R
(SVP, FINANCE, CHIEF ACCT OFFCR) |
A | Class A Common Stock | A | 21875 | $0.00 - $0.00 | $0 |
2024-01-10 | Vera Therapeutics, Inc. | COMMODORE CAPITAL LP
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 1050000 | $18.00 - $18.00 | $18,900,000 |
2023-12-29 | Vera Therapeutics, Inc. | Fordyce Marshall
(President and CEO) |
M | Class A Common Stock | A | 13516 | $2.32 - $2.90 | $38,853 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |